Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…

Biotechnology

DK, Bagsvaerd [HQ]

News

Theses · Events · Sentiments

Articles

24-11-06

Novo Nordisk Posts Strong 9-Month Growth, Shares Gain 4%

Novo Nordisk (NYSE:NVO) shares rose more than 4% pre-market today after the company reported …

Sentiments

24-11-06 -20.00%

Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply …

24-11-06 27.80%

Novo Nordisk is aware of 100 hospitalizations and 10 deaths resulting from people taking compounded copies of its popular weight-loss …

24-11-06 19.40%

Novo Nordisk (NYSE:NVO) reported better-than-expected third-quarter sales of its weight-loss drug Wegovy, reaching $2.49 billion, exceeding analyst expectations of $2.29 …

24-10-21 -40.00%

Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events …